These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17057045)

  • 1. Intrathecal topotecan in adult patients with neoplastic meningitis.
    Gammon DC; Bhatt MS; Tran L; Van Horn A; Benvenuti M; Glantz MJ
    Am J Health Syst Pharm; 2006 Nov; 63(21):2083-6. PubMed ID: 17057045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot study assessing a seven-day continuous intrathecal topotecan infusion for recurrent or progressive leptomeningeal metastatic cancer.
    Tran HC; Gardner S; Weiner HL; Liebes LF; Finlay JL
    J Oncol Pharm Pract; 2014 Jun; 20(3):229-32. PubMed ID: 23929729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies.
    Groves MD; Glantz MJ; Chamberlain MC; Baumgartner KE; Conrad CA; Hsu S; Wefel JS; Gilbert MR; Ictech S; Hunter KU; Forman AD; Puduvalli VK; Colman H; Hess KR; Yung WK
    Neuro Oncol; 2008 Apr; 10(2):208-15. PubMed ID: 18316473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis.
    Blaney SM; Heideman R; Berg S; Adamson P; Gillespie A; Geyer JR; Packer R; Matthay K; Jaeckle K; Cole D; Kuttesch N; Poplack DG; Balis FM
    J Clin Oncol; 2003 Jan; 21(1):143-7. PubMed ID: 12506183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases.
    Jaeckle KA; Dixon JG; Anderson SK; Moreno-Aspitia A; Colon-Otero G; Hebenstreit K; Patel TA; Reddy SL; Perez EA
    Cancer Med; 2020 Nov; 9(21):7935-7942. PubMed ID: 32885617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Favorable response of intraommaya topotecan for leptomeningeal metastasis of neuroblastoma after intravenous route failure.
    Sirachainan N; Visudtibhan A; Tuntiyatorn L; Pakakasama S; Chuansumrit A; Hongeng S
    Pediatr Blood Cancer; 2008 Jan; 50(1):169-72. PubMed ID: 16572404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen.
    Fizazi K; Asselain B; Vincent-Salomon A; Jouve M; Dieras V; Palangie T; Beuzeboc P; Dorval T; Pouillart P
    Cancer; 1996 Apr; 77(7):1315-23. PubMed ID: 8608509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine.
    Jaeckle KA; Phuphanich S; Bent MJ; Aiken R; Batchelor T; Campbell T; Fulton D; Gilbert M; Heros D; Rogers L; O'Day SJ; Akerley W; Allen J; Baidas S; Gertler SZ; Greenberg HS; LaFollette S; Lesser G; Mason W; Recht L; Wong E; Chamberlain MC; Cohn A; Glantz MJ; Gutheil JC; Maria B; Moots P; New P; Russell C; Shapiro W; Swinnen L; Howell SB
    Br J Cancer; 2001 Jan; 84(2):157-63. PubMed ID: 11161370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First human treatment of resistant neoplastic meningitis by intrathecal administration of MTX plus (125)IUdR.
    Rebischung C; Hoffmann D; Stefani L; Desruet MD; Wang K; Adelstein SJ; Artignan X; Vincent F; Gauchez AS; Zhang H; Fagret D; Vuillez J; Kassis AI; Balosso J
    Int J Radiat Biol; 2008 Dec; 84(12):1123-9. PubMed ID: 19061137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial of intrathecal administration of 5-fluoro-2'-deoxyuridine for treatment of meningeal dissemination of malignant tumors.
    Nakagawa H; Yamada M; Maeda N; Iwatsuki K; Hirayama A; Ikenaka K
    J Neurooncol; 1999; 45(2):175-83. PubMed ID: 10778733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis.
    Fleischhack G; Jaehde U; Bode U
    Clin Pharmacokinet; 2005; 44(1):1-31. PubMed ID: 15634030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intrathecal infusion of the antineoplastic agents for meningeal dissemination].
    Hodozuka A; Hayashi Y; Annei R; Hiroshima S; Saito M; Orimoto R; Sato M; Tanaka T
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):900-5. PubMed ID: 18633217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
    Glantz MJ; Jaeckle KA; Chamberlain MC; Phuphanich S; Recht L; Swinnen LJ; Maria B; LaFollette S; Schumann GB; Cole BF; Howell SB
    Clin Cancer Res; 1999 Nov; 5(11):3394-402. PubMed ID: 10589750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal 5-fluoro-2'-deoxyuridine (FdUrd) for the treatment of solid tumor neoplastic meningitis: an in vivo study.
    Nakagawa H; Yamada M; Fukushima M; Ikenaka K
    Cancer Chemother Pharmacol; 1999; 43(3):247-56. PubMed ID: 9923556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal chemotherapy with antineoplastic agents in children.
    Ruggiero A; Conter V; Milani M; Biagi E; Lazzareschi I; Sparano P; Riccardi R
    Paediatr Drugs; 2001; 3(4):237-46. PubMed ID: 11354696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoplastic meningitis from breast cancer: feasibility and activity of long-term intrathecal liposomal Ara-C combined with dose-dense temozolomide.
    Hoffmann AL; Buhk JH; Strik H
    Anticancer Res; 2009 Dec; 29(12):5191-5. PubMed ID: 20044635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Children's Oncology Group trial (P9962).
    Potter SL; Berg S; Ingle AM; Krailo M; Adamson PC; Blaney SM
    Pediatr Blood Cancer; 2012 Mar; 58(3):362-5. PubMed ID: 21910214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal administration of topotecan in nonhuman primates.
    Blaney SM; Cole DE; Godwin K; Sung C; Poplack DG; Balis FM
    Cancer Chemother Pharmacol; 1995; 36(2):121-4. PubMed ID: 7767947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptomeningeal carcinomatosis from breast cancer treated with intrathecal topotecan with concomitant intravenous eribulin.
    Salgia S; Fleming GF; Lukas RV
    J Clin Neurosci; 2014 Jul; 21(7):1250-1. PubMed ID: 24412296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies.
    Berg SL; Balis FM; Zimm S; Murphy RF; Holcenberg J; Sato J; Reaman G; Steinherz P; Gillespie A; Doherty K
    J Clin Oncol; 1992 Jan; 10(1):143-8. PubMed ID: 1727916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.